# Acorn Campus Ventures

> Acorn Campus Ventures is a VC fund backing Medical and Medical Device. See 5 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Cupertino, United States
- Total investments: 5
- Last investment: Sep 2014
- Lead investor: 0%
- Last updated: Aug 2026
- Website: http://www.acorncampus.com

Acorn Campus Ventures is a venture capital fund that provides private equity investments to firms in the wireless, semiconductor, photonics, internet, and life sciences industries. It was founded by David Tsang and is based in California.

## Contacts

5 contacts available for Acorn Campus Ventures. Shizune tracks 1 team members at Acorn Campus Ventures. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/acorn-campus-ventures?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 2 | 40% |
| Medical Device | 2 | 40% |
| Health Care | 1 | 20% |
| Life Science | 1 | 20% |
| Therapeutics | 1 | 20% |

8 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 2 | 40% |
| Series B | 1 | 20% |
| Series C | 1 | 20% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 2 | 40% |
| China | 1 | 20% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| David Tsang | Partner | 3 | https://shizune.co/investors/profile/david-tsang |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Eureka Therapeutics | Eureka Therapeutics is a biotechnology company that focuses on immunotherapies for the treatment of cancer. The company's platform is a novel T-cell therapy construct that mimics the natural biology of T-cells to fight cancer. It utilizes a paradigm-changing technology platform to develop fully-human antibodies against intracellular cancerantigens.Eureka Therapeutics was founded in 2006 and is headquartered in Emeryville, California. | $21M | Series C | Sep 23, 2014 |  |
| Innolight | InnoLight Technology is a leading high speed optical transceiver supplier in China, who researches, designs, builds and markets the best high-end optical transceivers (10G/40G/100G). We focus on the development of high-speed optical modules with characteristics of large capacity, small size, low power, low cost , to provide thebest-of-breed optical interconnect solutions for customers in areas such as cloud computing, data centers, data communication, long-distance transmission, wireless access, etc. Our value proposition is our leading-edge optical component and packaging technology, high speed optical module design know-how, and unique low-cost testing capability.InnoLight was founded in April 2008. The start-up team includes well-known U.S. venture capitalists, abroad returnees Dr., as well as excellent technical and marketing staff. Our clear goal is to combine the advanced technology and innovative company operating experience in Silicon Valley with Chinese outstanding talents and broad market, and to build a world-class high-end optical module company. |  | Series A | Apr 01, 2008 |  |
| Optovue | Optovue Corporation is an ophthalmic device company dedicated to working with eye care professionals and clinical researchers to lead the commercialization of new imaging modalities that improve diagnosis and therapy of ocular disease.Incorporated in December 2003 and located in Fremont California, Optovue was founded by pioneers of OpticalCoherence Tomography to develop the next generation ophthalmic diagnosis instrument based on the Fourier-Domain OCT technology. The ultra-high speed high resolution FD-OCT provides physicians with advanced retina diagnostic capabilities that will have significant benefit for patients who have retina conditions such as macular degeneration, diabetic retinopathy, glaucoma, and other macular diseases. | $10.5M | Series B | Mar 30, 2007 |  |
| Optovue | Optovue Corporation is an ophthalmic device company dedicated to working with eye care professionals and clinical researchers to lead the commercialization of new imaging modalities that improve diagnosis and therapy of ocular disease.Incorporated in December 2003 and located in Fremont California, Optovue was founded by pioneers of OpticalCoherence Tomography to develop the next generation ophthalmic diagnosis instrument based on the Fourier-Domain OCT technology. The ultra-high speed high resolution FD-OCT provides physicians with advanced retina diagnostic capabilities that will have significant benefit for patients who have retina conditions such as macular degeneration, diabetic retinopathy, glaucoma, and other macular diseases. |  | Series A | Jan 01, 2004 |  |
| Luxnet | Luxnet manufactures advanced optical components including photodiodes and laser diodes for high-speed networking. | $18M |  | Oct 11, 2001 |  |

5 of 5 investments shown.

## Co-investors
- [Harbinger Ventures](https://shizune.co/investors/profile/harbinger-ventures) — VC Fund, 3 deals together
- [H&Q Asia Pacific](https://shizune.co/investors/profile/h-a-asia-pacific) — VC Fund, 2 deals together
- [iD SoftCapital Group](https://shizune.co/investors/profile/id-softcapital-group) — VC Fund, 2 deals together
- [China Singapore Suzhou Industrial Park Ventures](https://shizune.co/investors/profile/china-singapore-suzhou-industrial-park-ventures-co) — VC Fund, 1 deal together
- [GAINS Investment Corp.](https://shizune.co/investors/profile/gains-investment-corp) — VC Fund, 1 deal together
- [iD Ventures America](https://shizune.co/investors/profile/id-ventures-america) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [National Development Fund of Taiwan Government](https://shizune.co/investors/profile/national-development-fund-of-taiwan-government) — VC Fund
- [Darwin Venture Management](https://shizune.co/investors/profile/darwin-venture-management) — VC Fund
- [AVA Angels](https://shizune.co/investors/profile/ava-angels) — VC Fund

## Featured in investor lists
- [Manufacturing Investors in Taiwan](https://shizune.co/investors/manufacturing-investors-taiwan)
- [Manufacturing VC Funds in Taiwan](https://shizune.co/investors/manufacturing-vc-funds-taiwan)
- [Climate Investors in Taiwan](https://shizune.co/investors/climate-investors-taiwan)
- [Climate VC Funds in Taiwan](https://shizune.co/investors/climate-vc-funds-taiwan)

## FAQ

### What does Acorn Campus Ventures invest in?

Acorn Campus Ventures invests primarily in Medical, Medical Device and Health Care startups, most often at Series A and Series B stage. Most of the 5 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Acorn Campus Ventures?

Public channels for Acorn Campus Ventures include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Acorn Campus Ventures?

The team at Acorn Campus Ventures includes David Tsang (Partner). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co